Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 501 to 550 of 2555

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Tezepelumab for treating severe asthmaTA880
Onasemnogene abeparvovec for treating spinal muscular atrophyHST15
Onasemnogene abeparvovec for treating presymptomatic spinal muscular atrophyHST24
Lumasiran for treating primary hyperoxaluria type 1HST25
Eladocagene exuparvovec for treating aromatic L-amino acid decarboxylase deficiencyHST26
Daytime intraoral neuromuscular electrical tongue stimulation using a removable device for obstructive sleep apnoeaHTG672
Endoscopic ultrasound-guided biliary drainage for biliary obstructionHTG673
Hypertension in pregnancy: diagnosis and managementNG133
AposHealth for knee osteoarthritisHTG671
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic gastric or gastro-oesophageal junction cancer after anti-HER2 treatment (terminated appraisal)TA879
Radiofrequency ablation for palliation of painful spinal metastasesHTG669
Radiofrequency ablation as an adjunct to balloon kyphoplasty or percutaneous vertebroplasty for palliation of painful spinal metastasesHTG670
Percutaneous thoracic duct embolisation for persistent chyle leakHTG666
Focal therapy using high-intensity focused ultrasound for localised prostate cancerHTG667
Maximal cytoreductive surgery for advanced ovarian cancerHTG668
UrgoStart for treating diabetic foot ulcers and leg ulcersHTG502
Macimorelin for diagnosing growth hormone deficiencyMIB320
Acute kidney injuryQS76
Finerenone for treating chronic kidney disease in type 2 diabetesTA877
Nivolumab with chemotherapy for neoadjuvant treatment of resectable non-small-cell lung cancerTA876
CaRi-Heart for predicting cardiac risk in suspected coronary artery disease: early value assessmentHTG663
Type 1 diabetes in adultsQS208
Asfotase alfa for treating paediatric-onset hypophosphatasiaHST23
Endoluminal gastroplication for gastro-oesophageal reflux diseaseHTG661
Percutaneous transluminal renal sympathetic denervation for resistant hypertensionHTG662
Eptinezumab for preventing migraineTA871
Cannabidiol for treating seizures caused by tuberous sclerosis complexTA873
Polatuzumab vedotin in combination for untreated diffuse large B-cell lymphomaTA874
Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma and primary mediastinal large B-cell lymphoma after 2 or more systemic therapiesTA872
Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin geneHST22
Ixazomib with lenalidomide and dexamethasone for treating relapsed or refractory multiple myelomaTA870
LIVERFASt for assessing and monitoring liver fibrosis, activity and steatosisMIB317
Mitapivat for treating pyruvate kinase deficiency (terminated appraisal)TA867
Urinary tract infections in adultsQS90
Vutrisiran for treating hereditary transthyretin-related amyloidosisTA868
Ambu aScope 4 RhinoLaryngo for visualising upper airways during rhinolaryngoscopyMIB316
Antenatal careQS22
Barrett's oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and managementNG231
Nivolumab with fluoropyrimidine- and platinum-based chemotherapy for untreated unresectable advanced, recurrent, or metastatic oesophageal squamous cell carcinomaTA865
Regorafenib for previously treated metastatic colorectal cancerTA866
Transvenous obliteration for gastric varicesHTG658
Biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancerHTG659
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 treatmentsTA862
Somatrogon for treating growth disturbance in children and young people aged 3 years and overTA863
Nintedanib for treating idiopathic pulmonary fibrosis when forced vital capacity is above 80% predictedTA864
Upadacitinib for treating active non-radiographic axial spondyloarthritisTA861
Aquablation robotic therapy for lower urinary tract symptoms caused by benign prostatic hyperplasiaMIB315
Delirium: prevention, diagnosis and management in hospital and long-term careCG103
Maribavir for treating refractory cytomegalovirus infection after transplantTA860
Ambu aScope 4 Broncho for routine diagnostic and therapeutic bronchoscopyMIB314

Results per page

  1. 10
  2. 25
  3. 50
  4. All